Navigation Links
Poniard Pharmaceuticals Reports Second Quarter 2008 Financial Results and Corporate Update
Date:7/31/2008

as 27 weeks for platinum-refractory and -resistant SCLC patients, a population for which there are very few treatment options.

-- Colorectal Cancer: Completed enrollment in our randomized, controlled Phase 2 trial in patients with CRC and presented positive preliminary results from this study at ASCO. Preliminary data suggested that picoplatin given once every four weeks in combination with 5-fluorouracil and leucovorin in the FOLPI regimen may have similar anti-tumor activity to oxaliplatin in combination with 5-fluorouracil and leucovorin in the FOLFOX regimen, which is the current standard of care in the first-line treatment of CRC.

We also presented expanded and updated results from our Phase 1 dose-escalation study in patients with CRC treated with FOLPI treatment administered every two or four weeks. None of the patients treated with picoplatin at doses of up to a cumulative dose of 1,350 mg/m2 exhibited severe neuropathy (Grade 3 or 4) in 62 evaluable patients. Current use of FOLFOX in CRC patients is associated with substantial neurotoxicity related to increasing cumulative doses of oxaliplatin at greater than 800 mg/m2. In addition, nephrotoxicities and ototoxicities were rare and mild with the FOLPI regimen.

-- Prostate Cancer: Presented preliminary safety and efficacy at ASCO data from our ongoing Phase 2 clinical trial of picoplatin in combination with docetaxel and prednisone, the standard of care for the first-line treatment of HRPC. Results to date demonstrated that picoplatin can be safely administered at full-dose docetaxel. Prostate specific antigen levels, or PSA normalized in 23 percent of patients. The data also demonstrated that reductions in PSA of at least 50 percent were achieved in 69 percent of evaluable patients. This compares favorably to published docetaxel treatment PSA response rates of approximately 45 percent.

-- Ovarian and Other Advanced Solid Tumors: Announced positive safety and efficacy data at ASCO
'/>"/>

SOURCE Poniard Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Poniard Pharmaceuticals Announces Upcoming Conference Participation
2. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
3. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
4. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
5. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
6. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
7. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
8. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
9. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
10. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
11. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... ... September 01, 2015 , ... ... Splashtop Business for Remote Support , a solution optimized for MSPs and IT ... the escalating renewal prices and inadequate customer services of existing remote support solution, ...
(Date:9/1/2015)... ... September 01, 2015 , ... Plaza OBGYN ... MonaLisa Touch® , an innovative vaginal health laser procedure that prevents and ... hormone-free treatment for atrophic vaginitis, a condition that causes vaginal dryness, pelvic discomfort, ...
(Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... The Jerry ... at The ACE Club and Green Valley Country Club in Lafayette Hill, PA. Over ... raised more than $13.5 million for programs and services designed to support patients and ...
(Date:9/1/2015)... ... September 01, 2015 , ... Discovia, a ... announced today that it has hired Scott Sanderson, an experienced business development professional ... Sanderson will be responsible for establishing and managing new client relationships in the ...
(Date:9/1/2015)... ... September 01, 2015 , ... Zecurion, a leading developer of data ... new version of endpoint DLP developed specifically for Mac OS. , In June 2015, ... 100 IT and information security professionals had participated. The beta test done by the ...
Breaking Medicine News(10 mins):Health News:Splashtop Launches Splashtop Business for Remote Support, the Simple, Reliable, and Cost-Effective Solution for MSPs and IT Professionals 2Health News:Splashtop Launches Splashtop Business for Remote Support, the Simple, Reliable, and Cost-Effective Solution for MSPs and IT Professionals 3Health News:Splashtop Launches Splashtop Business for Remote Support, the Simple, Reliable, and Cost-Effective Solution for MSPs and IT Professionals 4Health News:Houston's Plaza OB/GYN Now Offering the MonaLisa Touch® 2Health News:Houston's Plaza OB/GYN Now Offering the MonaLisa Touch® 3Health News:The 26th Jerry Segal Classic Returns to Benefit Patients of Magee Rehabilitation Hospital 2Health News:The 26th Jerry Segal Classic Returns to Benefit Patients of Magee Rehabilitation Hospital 3Health News:Former NFL Standout Scott Sanderson Joins eDiscovery Leader Discovia 2Health News:Zecurion Announces Endpoint Security for Mac 2
... an increased risk of death, by about 12 to 16% ... said a new research published in the latest issue of ... Neonatal and Developmental Medicine, Stanford University, who had done the ... their first month of life than later. Researchers have done ...
... Reddy Saturday administered a "defeat AIDS pledge"// to people ... ,India has 5.13 million people infected with HIV/AIDS. ... in the country with more than 400,000 affected people. ... HIV prevalence rate is an alarmingly 2.25 percent among ...
... easier to diagnose strokes affecting the left-brain than the ... of The Lancet.// ,The authors state that discrepancy ... of right-brain stroke. ,Cerebrovascular events are frequently accompanied ... the brain the lesion occurs. People with events on ...
... it can be marketed as functional food ingredients, or even ... have been able to identify the molecular structure of ... of different flavonols. They also say that they are able ... compounds tailored to specific needs. , ,Several studies in ...
... appears in the current edition of The Lancet said ... high risk from becoming infertile.//, ,Female genital mutilation ... World Health Organization estimates that more than 132 million ... that about 2million procedures are done every year. Few ...
... drug users and HIV infection was done by Chris ... Health. The results of the study showed that an ... countries of Afghanistan to Eastern Europe. “This HIV/AIDS ... ahead of our responses,” says Chris Beyrer. “Drug treatment ...
Cached Medicine News:Health News:"Defeat AIDS Pledge" by Andhra CM 2Health News:Stroke In The Right-Brain Can Remain Undiagnosed 2Health News:Girls Who Undergo Genital Mutilation Can Become Infertile 2Health News:HIV Infection Higher In Drug Trafficking Countries 2
(Date:9/1/2015)...   Millstone Medical Outsourcing announced today that the ... Olive Branch, MS. Now totaling over 270,000 ... has added the capacity required to meet the high demand ... gives us the opportunity to grow in parallel with our ... "Two and a half years ago we were operating only ...
(Date:9/1/2015)... Sept. 1, 2015   Ivenix Inc. , ... management system, closed on a $42M round of ... Ventures. Cardinal Partners, CICA, Inc., Easterly Capital, Fidelity ... the round. This financing will support the company,s ... Leerink Partners LLC acted as the exclusive placement ...
(Date:9/1/2015)... 1. September 2015 In nur zwei ... Mitarbeitern hat die SHL Group schnell weltweit 3.000 ... rapides Wachstum auf dem Markt der ... und das Management von SHL wieder. ... ist weltweit führend in Design und Herstellung automatischer ...
Breaking Medicine Technology:Millstone Medical Outsourcing Announces Olive Branch Expansion 2Ivenix Inc. Secures $42 Million in Funding 2Ivenix Inc. Secures $42 Million in Funding 3SHL Group erreicht wichtigen Markstein von 3.000 Mitarbeitern 2
... ROSWELL, Ga., Sept. 1, 2011 Kimberly-Clark Health ... a double-digit price increase on synthetic exam gloves ... of raw materials, particularly butadiene and acrylonitrile.   ... for these raw materials along with inflationary pressures ...
... month, Floridians are recognizing "Plasma Protein Therapies Month," by ... throughout the "Sunshine State" and for the rare, genetic ... through plasma donation. Plasma protein therapies, which ... biotechnology product), are used every day to treat people ...
Cached Medicine Technology:Floridians Recognized for Role in Helping Rare Disease Patients Who Need Lifesaving Therapies 2Floridians Recognized for Role in Helping Rare Disease Patients Who Need Lifesaving Therapies 3
...
No. 1. 30 mm conventional blades. Thin well-rounded tips....
Open blade speculum designed for both temporal and superior approach ocular surgery. Thumb screw adjusting mechanism. Manufactured in titanium....
Adjustable lid speculum angled 45 degrees with 17 mm curved solid blades and aspiration ports to remove excess fluid from around the eye during ocular procedures....
Medicine Products: